Squarepoint Ops LLC Beyond Spring Inc. Transaction History

Squarepoint Ops LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.13 - $2.66 $55,512 - $130,675	-49,126 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.68 - $5.01 $78,709 - $234,723	-46,851 Reduced 48.81%	49,126 $108,000
Q4 2021 Feb 14, 2022	BUY	$4.02 - $16.84 $385,827 - $1.62 Million	95,977 New	95,977 $435,000
Q1 2021 May 17, 2021	SELL	$10.61 - $15.77 $337,419 - $501,517	-31,802 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$10.21 - $17.31 $324,698 - $550,492	31,802 New	31,802 $388,000

Q1 2020 May 15, 2020	SELL	$9.68 - $18.47 $188,034 - $358,779	-19,425 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$11.83 - $18.68 $229,797 - $362,859	19,425 New	19,425 $301,000

5.44M

30.3K

1.8K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $95.4M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.